168 related articles for article (PubMed ID: 31599870)
1. Expanded table: statins.
Med Lett Drugs Ther; 2019 Sep; 61(1581):e152. PubMed ID: 31599870
[No Abstract] [Full Text] [Related]
2. Pitavastatin magnesium (Zypitamag) for hyperlipidemia.
Med Lett Drugs Ther; 2018 Jun; 60(1549):106. PubMed ID: 29913475
[No Abstract] [Full Text] [Related]
3. Lipid-lowering drugs.
Med Lett Drugs Ther; 2019 Feb; 61(1565):17-24. PubMed ID: 30845106
[No Abstract] [Full Text] [Related]
4. Bempedoic acid (Nexletol) for lowering LDL-cholesterol.
Med Lett Drugs Ther; 2020 Apr; 62(1595):53-55. PubMed ID: 32324179
[No Abstract] [Full Text] [Related]
5. Comparison table: Some lipid-lowering drugs.
Med Lett Drugs Ther; 2022 Sep; 64(1659):e152-e158. PubMed ID: 36094549
[No Abstract] [Full Text] [Related]
6. Lipid-lowering drugs.
Med Lett Drugs Ther; 2022 Sep; 64(1659):145-152. PubMed ID: 36094548
[No Abstract] [Full Text] [Related]
7. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Jones P; Kafonek S; Laurora I; Hunninghake D
Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
[TBL] [Abstract][Full Text] [Related]
8. Comparison table: Some lipid-lowering drugs.
Med Lett Drugs Ther; 2019 Feb; 61(1565):e24-e30. PubMed ID: 30845107
[No Abstract] [Full Text] [Related]
9. Which statin, what dose?
Drug Ther Bull; 2007 May; 45(5):33-7. PubMed ID: 17536493
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
11. In brief: Ezallor Sprinkle--a new formulation of rosuvastatin.
Med Lett Drugs Ther; 2019 Sep; 61(1581):152. PubMed ID: 31599869
[No Abstract] [Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
McKenney JM; Jones PH; Adamczyk MA; Cain VA; Bryzinski BS; Blasetto JW;
Curr Med Res Opin; 2003; 19(8):689-98. PubMed ID: 14687438
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials.
Kong SX; Crawford SY; Gandhi SK; Seeger JD; Schumock GT; Lam NP; Stubbings J; Schoen MD
Clin Ther; 1997; 19(4):778-97. PubMed ID: 9377621
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
Neuvonen PJ; Backman JT; Niemi M
Clin Pharmacokinet; 2008; 47(7):463-74. PubMed ID: 18563955
[TBL] [Abstract][Full Text] [Related]
19. The interaction of diltiazem with lovastatin and pravastatin.
Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
